These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7505085)

  • 1. Maternal serum screening for chromosome defects: human chorionic gonadotropin versus its free-beta subunit.
    Milunsky A; Nebiolo LM; Bellet D
    Fetal Diagn Ther; 1993; 8(4):221-4. PubMed ID: 7505085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
    N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
    Hsu JJ; Hsieh TT; Soong YK; Spencer K
    Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of maternal serum for fetal Down's syndrome in the first trimester.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Miller WA; Johnson A
    N Engl J Med; 1998 Apr; 338(14):955-61. PubMed ID: 9521983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of free beta-hCG in antenatal screening for Down's syndrome.
    Wald N; Densem J; Stone R; Cheng R
    Br J Obstet Gynaecol; 1993 Jun; 100(6):550-7. PubMed ID: 7687460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down's syndrome screening in multiple pregnancies using alpha-fetoprotein and free beta hCG.
    Spencer K; Salonen R; Muller F
    Prenat Diagn; 1994 Jul; 14(7):537-42. PubMed ID: 7526363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of maternal serum alpha-fetoprotein and free beta human chorionic gonadotrophin in the first trimester: implications for Down's syndrome screening.
    Berry E; Aitken DA; Crossley JA; Macri JN; Connor JM
    Prenat Diagn; 1995 Jun; 15(6):555-65. PubMed ID: 7544898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free beta human choriogonadotropin in Down's syndrome screening: a multicentre study of its role compared with other biochemical markers.
    Spencer K; Coombes EJ; Mallard AS; Ward AM
    Ann Clin Biochem; 1992 Sep; 29 ( Pt 5)():506-18. PubMed ID: 1280026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four-marker serum screening for Down's syndrome.
    Wald NJ; Densem JW; Smith D; Klee GG
    Prenat Diagn; 1994 Aug; 14(8):707-16. PubMed ID: 7527537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second trimester maternal serum screening using alpha fetoprotein, free beta human chorionic gonadotropin and maternal age specific risk: result of chromosomal abnormalities detected in screen positive for Down syndrome in an Asian population.
    Chao AS; Chung CL; Wu CD; Chang SD; Cheng PJ; Lin YT; Soong YK
    Acta Obstet Gynecol Scand; 1999 May; 78(5):393-7. PubMed ID: 10326883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha-fetoprotein, and age.
    Crossley JA; Aitken DA; Connor JM
    Prenat Diagn; 1991 Feb; 11(2):83-101. PubMed ID: 1712100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of gravidity on Down's syndrome screening with free beta hCG.
    Spencer K
    Prenat Diagn; 1995 Jan; 15(1):87-9. PubMed ID: 7537879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal serum free alpha-human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome.
    Wald NJ; Densem JW
    Prenat Diagn; 1994 Aug; 14(8):717-9. PubMed ID: 7527538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal serum Down syndrome screening: free beta-protein is a more effective marker than human chorionic gonadotropin.
    Macri JN; Kasturi RV; Krantz DA; Cook EJ; Moore ND; Young JA; Romero K; Larsen JW
    Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1248-53. PubMed ID: 1699417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal serum free beta hCG screening: results of studies including 480 cases of Down syndrome.
    Macri JN; Spencer K; Garver K; Buchanan PD; Say B; Carpenter NJ; Muller F; Boué A
    Prenat Diagn; 1994 Feb; 14(2):97-103. PubMed ID: 7514291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of an assay of the free beta-subunit of choriogonadotropin and its potential value in screening for Down's syndrome.
    Spencer K
    Clin Chem; 1991 Jun; 37(6):809-14. PubMed ID: 1710952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
    N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for Down's syndrome. The role of intact hCG and free subunit measurement.
    Spencer K
    Scand J Clin Lab Invest Suppl; 1993; 216():79-96. PubMed ID: 7690984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.